Published on 11/04/2020 11:2 | Source: ANI
For more videos Subscribe now! https://bit.ly/2YrTXdM and stay connected with us
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel https://t.me/InvestmentGuruIndia
Download Telegram App before Joining the Channel
New Delhi, :
A recent study suggests that a particular protein, GPR56, is involved in the biology of depression and the effect of antidepressants. The researchers believe that this protein could offer a novel target for new antidepressant drugs. Depression is a common psychiatric disorder and one of the leading causes of disability worldwide. Antidepressants are the first-line treatment for moderate to severe major depressive episodes. Despite their effectiveness, only 40% of patients respond to the first antidepressant they try. Mental illness associated with the risk of addiction and an increased risk of suicide.
Markets rally for third successive session on Wednesday
Outstanding performance by the bulls; Nifty ends around 15250 By Ruchit Jain, Angel Broking
Gold, Silver, Crude Oil, Natural Gas, Copper, Nickel, Zinc, Lead, Aluminium Commodity Report of 03 March 2021 By Geojit Financial
India's February services sector output rises: PMI
The BSE Sensex ended at 51,444.65 up by 1147.76 points or 2.28% - Jainam Share Consultant
